Symbols / MDLN Stock $44.76 -3.18% Medline Inc.

Healthcare • Medical Instruments & Supplies • United States • NMS
MDLN (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Medical Instruments & Supplies
CEO Mr. James M. Boyle
Exch · Country NMS · United States
Market Cap 37.85B
Enterprise Value 55.92B
Income 1.16B
Sales 28.43B
FCF (ttm) 791.25M
Book/sh 13.22
Cash/sh 2.43
Employees 45,000
Insider 10d —
IPO Dec 17, 2025
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 31.30
Forward P/E 27.06
PEG —
P/S 1.33
P/B 3.39
P/C —
EV/EBITDA 17.53
EV/Sales 1.97
Quick Ratio 2.21
Current Ratio 4.29
Debt/Eq 67.47
LT Debt/Eq —
EPS (ttm) 1.43
EPS next Y 1.65
EPS Growth 12.58%
Revenue Growth 14.80%
EPS Gr Q/Q -37.00%
Rev Gr Q/Q —
Earnings (next) 2026-05-06
Earnings (prior) 2026-02-25
ROA 3.66%
ROE 6.53%
ROIC —
Gross Margin 26.44%
Oper. Margin 5.69%
Profit Margin 4.08%
Shs Outstand 845.61M
Shs Float 322.82M
Insider Own 0.18%
Instit Own 95.61%
Short Float 4.79%
Short Ratio 2.66
Short Interest 18.67M
52W High 50.88
vs 52W High -12.02%
52W Low 34.89
vs 52W Low 28.29%
Beta —
Impl. Vol. 61.74%
Rel Volume 1.25
Avg Volume 5.84M
Volume 7.32M
Target (mean) $53.52
Tgt Median $55.00
Tgt Low $45.00
Tgt High $60.00
# Analysts 27
Recom Buy
Prev Close $46.23
Price $44.76
Change -3.18%
About

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam gloves, skin care and incontinence products, environment cleaning supplies, textiles, hand sanitizer, durable medical equipment, patient plastics, and decolonization and infection control products. Its surgical solutions provide operating room and perioperative environment product solutions, including surgical procedure trays, drapes and gowns, personal protective equipment, sterile wraps, surgical instruments, surgeon's gloves, procedure kits, and orthopedic implants. Its laboratory and diagnostics offer laboratory and diagnostic product solutions, including point of care testing, analyzers and instrumentation, lab and diagnostic consumables, diagnostic instruments, vital signs monitors, and anatomic pathology and phlebotomy products. It provides its products to domestic and international consumers. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands. It provides logistics and supply chain optimization services to domestic and international consumers. It also provides supply chain optimization services, such as consulting engagements, outsourced warehouse and technology management, put-away-ready packaging, third-party logistics, inventory rationalization, and route planning. The company was founded in 1966 and is based in Northfield, Illinois.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$53.52
Mean price target
2. Current target
$44.76
Latest analyst target
3. DCF / Fair value
$16.84
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$44.76
Low
$45.00
High
$60.00
Mean
$53.52

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-10 main JP Morgan Overweight → Overweight $53
2026-03-09 main Tigress Financial Buy → Buy $60
2026-03-09 reit BTIG Buy → Buy $55
2026-03-02 main Morgan Stanley Overweight → Overweight $52
2026-02-27 main Wells Fargo Equal-Weight → Equal-Weight $47
2026-02-26 main Citigroup Buy → Buy $60
2026-02-26 main UBS Buy → Buy $57
2026-02-26 main BMO Capital Outperform → Outperform $54
2026-02-26 main RBC Capital Outperform → Outperform $53
2026-02-26 main Evercore ISI Group Outperform → Outperform $55
2026-02-05 init Tigress Financial — → Buy $55
2026-01-12 init Citigroup — → Buy $48
2026-01-12 init Stifel — → Buy $46
2026-01-12 init Goldman Sachs — → Buy $49
2026-01-12 init Deutsche Bank — → Hold $40
2026-01-12 init Wolfe Research — → Outperform $47
2026-01-12 init Barclays — → Overweight $50
2026-01-12 init Wells Fargo — → Equal-Weight $42
2026-01-12 init BMO Capital — → Outperform $45
2026-01-12 init Evercore ISI Group — → Outperform $50
News
RSS: Latest MDLN news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-03-10 CARLYLE GROUP, INC. Beneficial Owner of more than 10% of a Class of Security — 26,105,840 $41.00 $1,070,339,440
2026-03-10 HELLMAN & FRIEDMAN CAPITAL PARTNERS X PARALLEL, L.P Beneficial Owner of more than 10% of a Class of Security — 26,131,237 $40.51 $1,058,524,148
2026-03-05 CARLYLE GROUP, INC. Beneficial Owner of more than 10% of a Class of Security — 9,297,883 — —
2026-03-05 HELLMAN & FRIEDMAN CAPITAL PARTNERS X PARALLEL, L.P Beneficial Owner of more than 10% of a Class of Security — 15,178,751 — —
2026-03-05 LAABS AMANDA H. Officer — 25,788 $0.00 $0
2026-03-05 ABRAMS WILLIAM J. Officer — 17,854 $0.00 $0
2026-03-05 MILLER STEPHEN L. Chief Operating Officer — 25,788 $0.00 $0
2026-03-05 GOLWAS DOUGLAS P. Officer — 25,788 $0.00 $0
2026-03-05 SHRYOCK CHRISTOPHER P. Officer — 11,903 $0.00 $0
2026-03-05 BOYLE JIM M. Chief Executive Officer — 31,739 $0.00 $0
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31
Total Revenue
28,432.00
Operating Revenue
28,432.00
Cost Of Revenue
20,914.00
Reconciled Cost Of Revenue
20,607.00
Gross Profit
7,518.00
Operating Expense
5,306.00
Selling General And Administration
4,524.00
Other Operating Expenses
78.00
Total Expenses
26,220.00
Operating Income
2,212.00
Total Operating Income As Reported
2,212.00
EBITDA
3,071.00
Normalized EBITDA
3,159.00
Reconciled Depreciation
1,011.00
EBIT
2,060.00
Total Unusual Items
-88.00
Total Unusual Items Excluding Goodwill
-88.00
Net Income
1,159.00
Pretax Income
1,248.00
Net Non Operating Interest Income Expense
-812.00
Interest Expense Non Operating
812.00
Net Interest Income
-812.00
Interest Expense
812.00
Other Income Expense
-152.00
Other Non Operating Income Expenses
-64.00
Gain On Sale Of Security
-88.00
Tax Provision
91.00
Tax Rate For Calcs
0.00
Tax Effect Of Unusual Items
-6.42
Net Income Including Noncontrolling Interests
1,157.00
Net Income From Continuing Operation Net Minority Interest
1,159.00
Net Income From Continuing And Discontinued Operation
1,159.00
Net Income Continuous Operations
1,157.00
Minority Interests
2.00
Normalized Income
1,240.58
Net Income Common Stockholders
1,159.00
Diluted EPS
1.43
Basic EPS
1.43
Basic Average Shares
812.00
Diluted Average Shares
812.00
Diluted NI Availto Com Stockholders
1,159.00
Amortization
704.00
Amortization Of Intangibles Income Statement
704.00
Depreciation Amortization Depletion Income Statement
704.00
Depreciation And Amortization In Income Statement
704.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31
Total Assets
38,484.00
—
—
Current Assets
10,679.00
—
—
Cash Cash Equivalents And Short Term Investments
1,939.00
—
—
Cash And Cash Equivalents
1,939.00
—
—
Receivables
3,533.00
—
—
Accounts Receivable
3,533.00
—
—
Gross Accounts Receivable
3,685.00
—
—
Allowance For Doubtful Accounts Receivable
-152.00
—
—
Inventory
4,769.00
—
—
Raw Materials
748.00
—
—
Finished Goods
4,021.00
—
—
Other Current Assets
438.00
—
—
Total Non Current Assets
27,805.00
—
—
Net PPE
4,778.00
—
—
Goodwill And Other Intangible Assets
21,972.00
—
—
Goodwill
8,079.00
—
—
Other Intangible Assets
13,893.00
—
—
Non Current Deferred Assets
583.00
0.00
—
Non Current Deferred Taxes Assets
583.00
0.00
—
Other Non Current Assets
472.00
—
—
Total Liabilities Net Minority Interest
19,198.00
—
—
Current Liabilities
2,490.00
—
—
Payables And Accrued Expenses
1,539.00
—
—
Payables
1,072.00
—
—
Accounts Payable
961.00
—
—
Current Accrued Expenses
467.00
—
—
Total Tax Payable
111.00
—
—
Income Tax Payable
24.00
—
—
Current Debt And Capital Lease Obligation
143.00
—
—
Current Debt
77.00
—
—
Other Current Borrowings
77.00
—
—
Current Capital Lease Obligation
66.00
—
—
Other Current Liabilities
808.00
—
—
Total Non Current Liabilities Net Minority Interest
16,708.00
—
—
Long Term Debt And Capital Lease Obligation
12,484.00
—
—
Long Term Debt
12,484.00
—
—
Other Non Current Liabilities
4,224.00
—
—
Stockholders Equity
10,737.00
-35.02%
16,524.00
+29943.64%
55.00
Common Stock Equity
10,737.00
-35.02%
16,524.00
+29943.64%
55.00
Capital Stock
0.00
0.00
—
Common Stock
0.00
0.00
—
Preferred Stock
0.00
0.00
—
Share Issued
812.00
+0.00%
812.00
+1.53%
799.80
Ordinary Shares Number
812.00
+0.00%
812.00
+1.53%
799.80
Additional Paid In Capital
10,717.00
0.00
—
Retained Earnings
-7.00
0.00
—
Gains Losses Not Affecting Retained Earnings
27.00
-99.83%
16,158.00
—
Minority Interest
8,549.00
0.00
—
Other Equity Adjustments
27.00
-99.83%
16,158.00
—
Total Equity Gross Minority Interest
19,286.00
—
—
Total Capitalization
23,221.00
—
—
Working Capital
8,189.00
—
—
Invested Capital
23,298.00
-29.44%
33,018.00
+99.24%
16,572.00
Total Debt
12,627.00
—
—
Net Debt
10,622.00
—
—
Capital Lease Obligations
66.00
—
—
Net Tangible Assets
-11,235.00
-84.18%
-6,100.00
+72.60%
-22,265.00
Tangible Book Value
-11,235.00
-84.18%
-6,100.00
+72.60%
-22,265.00
Interest Payable
144.00
—
—
Limited Partnership Capital
—
16,384.00
-2.09%
16,734.00
Other Equity Interest
—
366.00
—
Total Partnership Capital
—
16,395.00
-3.11%
16,922.00
Line Item Trend 2025-12-31 2023-12-31
Operating Cash Flow
1,744.00
—
Cash Flow From Continuing Operating Activities
1,744.00
—
Net Income From Continuing Operations
1,157.00
—
Depreciation Amortization Depletion
1,011.00
—
Depreciation And Amortization
1,011.00
—
Other Non Cash Items
144.00
-32.08%
212.00
Stock Based Compensation
76.00
—
Provisionand Write Offof Assets
54.00
—
Operating Gains Losses
85.00
+2733.33%
3.00
Gain Loss On Investment Securities
-41.00
—
Net Foreign Currency Exchange Gain Loss
68.00
—
Change In Working Capital
-783.00
-493.47%
199.00
Change In Receivables
-355.00
—
Changes In Account Receivables
-355.00
—
Change In Inventory
-264.00
—
Change In Payables And Accrued Expense
-19.00
—
Change In Accrued Expense
-92.00
—
Change In Payable
73.00
—
Change In Account Payable
73.00
—
Change In Other Current Assets
-126.00
—
Change In Other Current Liabilities
-19.00
+20.83%
-24.00
Investing Cash Flow
-474.00
—
Cash Flow From Continuing Investing Activities
-474.00
—
Net PPE Purchase And Sale
-447.00
—
Purchase Of PPE
-447.00
-62.55%
-275.00
Capital Expenditure
-447.00
-62.55%
-275.00
Net Business Purchase And Sale
6.00
—
Net Other Investing Changes
-33.00
-57.14%
-21.00
Financing Cash Flow
399.00
—
Cash Flow From Continuing Financing Activities
399.00
—
Net Issuance Payments Of Debt
-4,092.00
—
Issuance Of Debt
7,748.00
—
Repayment Of Debt
-11,840.00
—
Long Term Debt Issuance
7,748.00
—
Long Term Debt Payments
-11,840.00
—
Net Long Term Debt Issuance
-4,092.00
—
Net Common Stock Issuance
5,045.00
—
Common Stock Payments
-2,003.00
—
Common Stock Dividend Paid
-518.00
—
Cash Dividends Paid
-518.00
—
Repurchase Of Capital Stock
-2,003.00
—
Net Other Financing Charges
-36.00
—
Changes In Cash
1,669.00
—
Effect Of Exchange Rate Changes
23.00
—
Beginning Cash Position
250.00
—
End Cash Position
1,942.00
—
Free Cash Flow
1,297.00
-8.01%
1,410.00
Interest Paid Supplemental Data
944.00
—
Income Tax Paid Supplemental Data
62.00
—
Common Stock Issuance
7,048.00
0.00
Issuance Of Capital Stock
7,048.00
0.00
Sale Of Business
6.00
—
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category